CYRX vs CDNA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 14, 2026

CYRX

72.8
AI Score
VS
CYRX Wins

CDNA

34.0
AI Score

Investment Advisor Scores

CYRX

73score
Recommendation
BUY

CDNA

34score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CYRX CDNA Winner
Revenue 96.77M 249.65M CDNA
Net Income -18.80M 113.44M CDNA
Net Margin -19.4% 45.4% CDNA
Operating Income -19.65M 114.42M CDNA
ROE -3.8% 26.7% CDNA
ROA -2.5% 21.3% CDNA
Total Assets 756.20M 532.99M CYRX
Cash 269.27M 373.64M CDNA
Current Ratio 2.08 4.58 CDNA
Free Cash Flow -14.22M 29.26M CDNA

Relative Price Performance (Last 90 Days)

CYRX 1M: +6.3% · 3M: +16.7% CDNA 1M: +27.9% · 3M: +119.6%

Current Technical Phase

CYRX

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.9% over 20 days), RSI 58

RSI (14): 57.5 · Price: $16.34

CDNA

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (34.3% over 20 days), RSI 67

RSI (14): 66.6 · Price: $47.50

Fundamentals Snapshot

Metric CYRX CDNA
Market Cap
Forward P/E -24.6 35.1
Trailing P/E 23.4
Revenue (TTM)
Revenue Growth 0.1% 0.5%
Gross Margin 0.5% 0.7%
Operating Margin -0.2% 0.0%
EPS -0.82 2.08
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, CYRX is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.